TrialOncotarget2015

Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients.

Isabel Stückrath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.